The authors state that long-term inflammation in patients with inflammatory bowel disease mediates the RANKL/NF-kB pathway and the use of hormones, which may contribute to the development of osteosarcopenia. They also emphasize the endocrine interaction between osteocytes and myocytes. The gene discussed is NFKB1; the disease is inflammatory bowel disease.